Home › Liposarcoma › Illinois › Chicago

Liposarcoma clinical trials in Chicago, IL

5 studies for Liposarcoma are looking for participants at sites in and around Chicago (within about 30 miles). Open a study to see who can join and how to contact the study team.

A Phase 3 Study of Ersodetug in Patients With Tumor Hyperinsulinism

RecruitingPhase 3

Investigative Site, Chicago

Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT06881992

Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Poorly Differentiated Sarcomas

RecruitingPhase 3

Northwestern University, Chicago
University of Illinois, Chicago
University of Chicago Comprehensive Cancer Center, Chicago
and 1 more

Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT06422806

Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma

RecruitingPhase 3

Rush University Medical Center, Chicago
University of Illinois at Chicago MBCCOP, Chicago

Ages 18 and older · All sexes · Updated Sep 10, 2026 · NCT04031677

Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced Sarcoma

RecruitingPhase 1

University of Chicago Comprehensive Cancer Center, Chicago

Ages 18 and older · All sexes · Updated Sep 4, 2026 · NCT05711615

NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)

RecruitingPhase 1/2

Lurie Children's Hospital of Chicago, Chicago

Up to age 30 · All sexes · Updated Aug 3, 2026 · NCT06239272

Liposarcoma trials in other cities

Other studies in Chicago

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.